Eikenella corrodens is a slow-growing, gram-negative, nonmotile, facultative rod that can cause infection in humans. Although the clinical characteristics of Eikenella infections in adults are well described, the literature regarding Eikenella infections in children is lacking. Thirteen cases of Eikenella infection in children and adolescents reported from a hospital and an additional 41 cases from the literature were reviewed. Eikenella species can be serious pediatric pathogens, particularly when there is an exposure to human oral secretions. Empirical therapy used to manage most oropharyngeal flora may be ineffective against Eikenella species. The treatment of choice for children and adolescents who are infected with Eikenella species includes a combination of surgical management and antibiotics.
Three days after discharge, the patient's mother noticed drainage from the patient's right knee. He was then admitted to Rainbow Babies and Children's Hospital, where he began to receive treatment with ceftriaxone, 100 mg/kg q.d., and vancomycin, 60 mg/kg q.d. The patient was afebrile, and his vital signs were within normal limits. Physical examination was remarkable for warmth, tenderness, and edema of the right knee. There was decreased range of motion of the right knee and associated pain on range of motion. The erythrocyte sedimentation rate (ESR) was 1150 mm/h. A complete blood count revealed a WBC count of cells/L, with a differential of 9 6 ϫ 10 48% neutrophils, 42% lymphocytes, 8% monocytes, and 0.8% eosinophils. Needle aspiration of the right knee was performed. The joint fluid had a WBC count of cells/L, with a 9 158 ϫ 10 differential of 98% neutrophils, 11% lymphocytes, and 1% monocytes. The RBC count was cells/L and there were 9 31 ϫ 10 no crystals. The Gram stain revealed granulocytes (4ϩ), but no organisms were seen. Culture of synovial fluid yielded 2 colonies of E. corrodens. The results of a bone scan were negative for osteomyelitis. The patient completed 21 days of treatment with iv ceftriaxone, 100 mg/kg q.d., with resolution of signs and symptoms.
Patient 2. A 14-year-old previously healthy boy who had a history of nail biting was admitted to the hospital with a 1-week history of a swollen and tender left fourth finger. Five days before admission to the hospital, he pierced his finger with a needle and expressed purulent discharge. This transiently decreased his pain and swelling. He was evaluated by his pediatrician 3 days prior to admission to the hospital and he began receiving treatment with oral amoxicillin-clavulanic acid, 500 mg t.i.d. The patient's symptoms worsened, and the patient was referred to the emergency department. There, the patient was noted to be afebrile with normal vital signs. An examination of the patient was remarkable for an edematous and tender left fourth finger with limited range of motion at the distal interphalangeal joint. Purulence was visible under the nail bed. The ESR was 38 mm/h, and the WBC count was cells/ 9 11.5 ϫ 10 L, with a differential of 58% neutrophils, 32% lymphocytes, 8% monocytes, and 2% eosinophils. A radiograph of the finger did not reveal abnormalities. The patient was admitted to the hospital, and the infected area was incised and drained. The patient was treated with iv penicillin G, U q6h, and 6 1 ϫ 10 clindamycin, 600 mg q6h. A Gram stain revealed gram-negative bacilli, gram-positive cocci, and granulocytes (4ϩ). Culture of the purulent material yielded E. corrodens as well as coagulasenegative staphylococci and a-hemolytic streptococci. The patient continued treatment with clindamycin for 4 days and was discharged receiving treatment with oral amoxicillin-clavulanic acid, 500 mg t.i.d., for an additional week.
PATIENTS AND METHODS

Patient population.
Computerized records from the clinical microbiology laboratory at Rainbow Babies and Children's Hospital were reviewed for culture results that were positive for Eikenella for patients р18 years old during 1994-1999. Thirteen patients were found, and a review of medical records was possible for 11 of these patients. The microbiology department was able to provide some information regarding the 2 additional patients through specimen culture records.
Microbiology. Isolates of Eikenella species were identified as a slow-growing, gram-negative, nonmotile, facultative rod that grew well on blood agar in 5% carbon dioxide. The characteristic pitting of the agar, greenish discoloration around the colonies, and a musty or bleach-like odor helped our laboratory identify this organism. The biochemical tests that our laboratory used showed Eikenella species to be oxidase positive, catalase negative, and indole negative. Antimicrobial susceptibility testing is not typically done for Eikenella species at Rainbow Babies and Children's Hospital.
Literature search. Previous reports of infection with Eikenella species were found by means of a Medline search for articles containing the key word "Eikenella" that were written from 1966 through June 1999. The search was further limited to articles that discussed extraperiodontal disease. Pediatric cases were identified by a review of each individual article.
Data collection. The cases of Eikenella infection at Rainbow Babies and Children's Hospital as well as those found in the literature search were selected and the following patient data were collected: age, sex, site of isolation, predisposing condition, WBC count, ESR, other organisms isolated, surgical intervention, and definitive antibiotic therapy, duration of treatment, and outcome. Several review articles did not provide specific details about each patient and, therefore, were not included in the review [32] [33] [34] [35] [36] [37] [38] [39] .
RESULTS
Results were calculated from data collected from cases at Rainbow Babies and Children's Hospital and those reported in the literature (tables 1-4). A total of 54 cases of Eikenella infection in children and adolescents were reviewed (13 cases from our hospital and 41 cases from the literature).
Population characteristics. The age of patients with Eikenella infection ranged from 6 months to 18 years (median, 9 years). There were 24 female and 30 male patients in our review.
Laboratory and microbiology. WBC counts ranged from cells/L to cells/L. The ESR ranged from 36 9 9 5.2 ϫ 10 29.8 ϫ 10 to 1150 mm/h in patients for whom it was reported. Complete microbiology findings were not reported for 7 of the 54 patients. Of the remaining 47 patients, 17 were infected with E. corrodens Clinical presentation. The most common locations of Eikenella infections were the head and neck, followed by infections located in the extremities, scalp, and face. The distribution of infections is shown in table 2.
Underlying condition. Of the patients who had significant antecedent comorbidity, the majority of Eikenella infections were otolaryngeal or gastrointestinal. Details of the patients' underlying conditions were available for 51 of the 54 patients. Of these 51 patients, 14 were healthy, 2 had mental retardation, 2 had insulin-dependent diabetes mellitus, 2 had leukemia, and 2 had cardiac disease. Seven patients had various gastrointestinal problems, including a perforated viscus and hepatic dysfunction. Ten other patients had antecedent head and neck infections. Trauma accounted for the cases of infection in 8 other patients. Two patients had Eikenella bacteremia.
Therapy. Clinical success in treatment of E. corrodens was a Gm was given for 2 weeks and Ctri was given for 6 weeks. b Pen and Cm were given for 2 days and 4 days, respectively; Aug was given for 7 days.
achieved with the use of a wide range of antibiotics. These antibiotics included ampicillin, penicillin G, amoxicillin-clavulanic acid, cephalexin, ceftriaxone, vancomycin, amikacin, cefazolin, amoxicillin, gentamicin, chloramphenicol, clindamycin, piperacillin with tazobactam, and tobramycin. Six patients were discharged to their homes receiving treatment with ampicillin, 5 were receiving penicillin, 3 were receiving amoxicillin-clavulanic acid, 1 was receiving amoxicillin, and 4 were receiving clindamycin in combination with another antibiotic (b-lactam and/or aminoglycoside). The duration of therapy ranged from 3 days to 8 weeks. Information regarding surgery was not available for 14 of the 54 patients. Of the remaining 40 patients, 36 required incision and drainage in addition to antibiotic therapy.
Outcome. The majority of patients required a surgical procedure in addition to antibiotic therapy to obtain clinical resolution. Specifically, 16 of the 20 patients with successful recovery had undergone 1 surgical procedure. Of these 16 patients, 9 recovered, 1 had a residual pleural effusion, 1 had a delayed response, 1 had wound dehiscence, 1 had empyema, 1 had hemiparesis, and 2 died. Six patients required a second surgical intervention, 5 of whom recovered and 1 of whom had a residual complication of ataxia and 6th nerve palsy.
DISCUSSION
Eikenella infections have been described primarily in adults.
The majority of infections involve the CNS, skin, bone, peritoneal fluid, hands, conjunctiva, lacrimal duct, cervix, cheek, joint, heart, and abdomen [40] . Our review shows that E. corrodens can also be a significant pathogen in children. Because Eikenella species is typically found in the oropharynx, it is not surprising that most infections (22 [ reflect a selection bias, because unusual or severe cases are more likely to be reported.
Antibiotics that are often used for empirical treatment of infection caused by oropharyngeal flora may be ineffective against Eikenella species. This organism is typically susceptible to many antibiotics, including penicillin G, ceftriaxone, ampicillin, amoxicillin-clavulanic acid, trimethoprim-sulfamethoxazole, and fluoroquinolones [11] . However, it is usually resistant to clindamycin, cephalexin, erythromycin, and metronidazole. b-lactamase production by E. corrodens is rare. In addition, the blactamase produced by these strains can be inhibited by the use of clavulanate or sulbactam [41] . Antibiotics selected for management of infection after surgical drainage are often chosen to manage coinfecting organisms and not Eikenella species. This is illustrated in patient 2, for whom Eikenella species may not have been considered a serious pathogen.
It appears that coinfection with other organisms is common. However, the virulence of this organism appears to be significant regardless of the number of pathogens. Of the 47 children and adolescents with Eikenella infections for whom microbiological data were known, 17 (36.2%) of them were infected with Eikenella species alone and 30 (63.8%) had polymicrobial infections. Fifty percent of the cultures of mixed isolates contained streptococci. This suggests there might be synergy in the pathogenicity of Eikenella species and streptococci. In addition, only 2 of the 30 patients with polymicrobial infections were coinfected with Actinomyces species, another common oropharyngeal pathogen. Despite this low occurrence, this coinfection resulted in osteomyelitis in both patients.
Evaluation of laboratory parameters showed that the ESR was a better indicator of Eikenella infection than was the WBC count. Although the WBC count ranged from cells/ 9 5.2 ϫ 10 L to cells/L, the ESR was universally elevated. For 9 29.8 ϫ 10 example, patient 1, a 3-year-old boy, had a puncture wound in the right knee. His ESR was 1150 mm/h but his WBC count was only cells/L. In the children and adolescents that 9 6 ϫ 10 we describe, previous or concomitant illness had a greater association with Eikenella infections than did a previously healthy status. Of the 51 patients with a known patient history, 37 (72.5%) had an underlying condition, including 8 patients (15.7%) who had trauma and 7 patients (13.7%) who had gastrointestinal infections. Other underlying conditions included chronic diseases, such as mental retardation with cerebral palsy, Down's syndrome, diabetes, and leukemia. Only 14 Eikenella-infected patients (27.5%) were previously healthy.
Outcomes were recorded for 23 patients. We found that surgery is critical for a favorable outcome. For example, both patients 1 and 2 were initially receiving appropriate antibiotic therapy, but clinical improvement resulted only after surgical intervention. In addition, patient 2 was later treated with an antibiotic that is not typically effective for management of Eikenella species. The patient continued to show clinical improvement, which illustrates the fact that surgical drainage may be more important than antibiotics alone in the management of Eikenella infections. Ninety percent of the patients identified from the review of the literature required a surgical procedure. Of the 9 patients for whom Eikenella was the single pathogen, only 6 recovered with antibiotic therapy and/or 1 surgical procedure. Of the remaining 3 reported cases, 2 patients required a second surgical procedure, and 1 patient died. Of the 14 patients with polymicrobial infections, 10 had associated complications. Unfortunately, there is no reported outcome for the 4 patients who did not undergo any surgical treatment.
In conclusion, this review shows that Eikenella species is a serious pathogen in children and adolescents. This is especially true when there is an exposure to human oral secretions. Coinfection with other organisms is common. Depending on the location of infection, the treatment of choice is a combination of surgical management and antibiotics, such as ampicillin or penicillin. Antibiotics that are typically effective against oropharyngeal flora, such as clindamycin and metronidazole, are ineffective against Eikenella species. To avoid a delay in diagnosis, the clinician should have a high index of suspicion for Eikenella species as a cause of serious infections.
